연구동향 분석

Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma

유승연 이지애 신윤주 조남윤 배정모 강경훈 2019년

논문상세정보
인용/피인용
' Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Prognosis
  • SMAD4
  • biomarker
  • colorectal neoplasms
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,094 0

0.0%

' Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma' 의 참고문헌

  • Transforming growth factor beta superfamily signaling in development of colorectal cancer
    Jung B [2017]
  • Transforming growth factor beta stimulation of colorectal cancer cell lines : type II receptor bypass and changes in adhesion molecule expression
    Ilyas M [1999]
  • Transforming growth factor beta signaling in colorectal cancer cells with microsatellite instability despite biallelic mutations in TGFBR2
  • The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells
    Deckers M [2006]
  • The role of TGF-beta/SMAD4 signaling in cancer
    Zhao M [2018]
  • The epithelial-mesenchymal transition (EMT) phenomenon
    Savagner P. [2010]
  • The Smad4/PTEN Expression Pattern Predicts Clinical Outcomes in Colorectal Adenocarcinoma
    Yumin Chung [2018]
  • The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4and p53 status in CRC
  • TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma : a retrospective study
    Bacman D [2007]
  • Smad4 may help to identify a subset of colorectal cancer patients with early recurrence after curative therapy
    Ahn BK [2011]
  • Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer
    Kozak MM [2015]
  • Smad4 and epithelial-mesenchymal transition proteins in colorectal carcinoma : an immunohistochemical study
    Ioannou M [2018]
  • Significance of positive and inhibitory regulators in the TGF-beta signaling pathway in colorectal cancers
    Coates RF [2017]
  • SMAD4/DPC4 expression and prognosis in human colorectal cancer
  • SMAD4 protein expression and cell proliferation in colorectal adenocarcinomas
  • SMAD4 loss in colorectal cancer patients correlates with recurrence, loss of immune infiltrate, and chemoresistance
    Wasserman I [2019]
  • SMAD4 levels and response to 5-fluorouracil in colorectal cancer
    Alhopuro P [2005]
  • SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
    Boulay JL [2002]
  • SMAD4 as a prognostic marker in colorectal cancer
    Alazzouzi H [2005]
  • SMAD4 alteration associates with invasive-front pathological markers and poor prognosis in colorectal cancer
    Oyanagi H [2019]
  • Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer
    Gulubova M [2010]
  • Reduced expression of SMAD4is associated with poor survival in colon cancer
    Yan P [2016]
  • QuPath : open source software for digital pathology image analysis
    Bankhead P [2017]
  • Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy : a translational study of the AIO colorectal study group
  • Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients
    Mesker WE [2009]
  • Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta
    Baker K [2007]
  • Meta-analysis of the prognostic value of smad4 immunohistochemistry in various cancers
    Du Y [2014]
  • Low expression of transforming growth factor beta-1 in cancer tissue predicts a poor prognosis for patients with stage III rectal cancers
    Chun HK [2014]
  • Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway
    Zhang B [2014]
  • Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis
    Xie W [2003]
  • Loss of SMAD4 promotes lung metastasis of colorectal cancer by accumulation of CCR1+ tumorassociated neutrophils through CCL15-CCR1 axis
    Yamamoto T [2017]
  • Loss of SMAD4 promotes colorectal cancer progression by accumulation of myeloid-derived suppressor cells through the CCL15-CCR1 chemokine axis
    Inamoto S [2016]
  • Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis
    Itatani Y [2013]
  • Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients
    Bae JM [2015]
  • Key elements of the BMP/SMAD pathway co-localize with CDX2 in intestinal metaplasia and regulate CDX2 expression in human gastric cell lines
    Barros R [2008]
  • Juvenile polyps have gastric differentiation with MUC5AC expression and downregulation of CDX2 and SMAD4
    Barros R [2009]
  • High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer
    Wang C [2015]
  • High SMAD4 levels appear in microsatellite instability and hypermethylated colon cancers, and indicate a better prognosis
  • Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36cancers in 185 countries
    Bray F [2018]
  • Frequent loss of SMAD4/DPC4 protein in colorectal cancers
    Salovaara R [2002]
  • Expression of TGFbeta1, TbetaRII and Smad4 in colorectal carcinoma
    Xu WQ [2007]
  • Expression of Smad4 and TGF-beta2 in colorectal carcinoma
    Kouvidou C [2006]
  • Evaluation of the prognostic value of pSMAD immunohistochemistry in colorectal cancer
  • Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system
    Bae JM [2017]
  • DPC4/SMAD4 gene alterations in human cancer, and their functional implications
    Schutte M. [1999]
  • CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
  • Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas : a systematic review and meta-analysis
    Wang JD [2017]
  • Association of overexpression of TIF1gamma with colorectal carcinogenesis and advanced colorectal adenocarcinoma
    Jain S [2011]
  • Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes
    Deacu E [2004]
  • A review of juvenile polyposis syndrome
    Chow E [2005]
  • A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer
    Boland CR [1998]
  • A Meta-analysis of SMAD4 immunohistochemistry as a prognostic marker in colorectal cancer